Product news

Share this article:
FDA has approved an NDA for LoSeasonique, an oral contraceptive manufactured by Duramed, a subsidiary of Barr Pharmaceuticals.
 
Eli Lilly & Co. has announced the introduction of a color differentiation system for U-100 insulin products marketed in the US, including vials, pens and individual packaging for Humalog and Humulin
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

FDA lifts OncoMed partial hold

The FDA froze the clinical trial of anti-Fzd7 vantictumab in July over concern about "bone-related adverse events."

Research links estrogen and binge eating

Baylor College of Medicine researchers have found that an estrogen replacement suppressed binge-eating behavior among lab mice.

Apple selfies spur diabetes donations

Jazz apples has launched a Crunch to Contribute campaign to raise money for one of two diabetes associations.